Florian Rüker

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Metastatic Breast Cancer

Atopic Dermatitis

Monoclonal Antibody

Top Venues

International journal of molecular sciences

Journal of extracellular vesicles

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Aleksandra Rodak, Katharina Stadlbauer, Madhusudhan Reddy Bobbili, Oskar Smrzka, Florian Rüker, Gordana Wozniak-Knopp
Development of a Cytotoxic Antibody-Drug Conjugate Targeting Membrane Immunoglobulin E-Positive Cells. International journal of molecular sciences 24 (19) (2023)
Katharina Stadlbauer, Peter Andorfer, Gerhard Stadlmayr, Florian Rüker, Gordana Wozniak-Knopp
Bispecific mAb 2 Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab. International journal of molecular sciences 23 (9) (2022)
Stefan Vogt, Madhusudhan Reddy Bobbili, Gerhard Stadlmayr, Katharina Stadlbauer, Jørgen Kjems, Florian Rüker, Johannes Grillari, Gordana Wozniak-Knopp
An engineered CD81-based combinatorial library for selecting recombinant binders to cell surface proteins: Laminin binding CD81 enhances cellular uptake of extracellular vesicles. Journal of extracellular vesicles 10 (11) (2022)
Filippo Benedetti, Katharina Stadlbauer, Gerhard Stadlmayr, Florian Rüker, Gordana Wozniak-Knopp
A Tetravalent Biparatopic Antibody Causes Strong HER2 Internalization and Inhibits Cellular Proliferation. Life (Basel, Switzerland) 11 (11) (2021)
Aleksandra Rodak, Gerhard Stadlmayr, Katharina Stadlbauer, Dominic Lichtscheidl, Madhusudhan Reddy Bobbili, Florian Rüker, Gordana Wozniak-Knopp
Bispecific T-Cell Engagers Targeting Membrane-Bound IgE. Biomedicines 9 (11) (2021)
Stefan Vogt, Gerhard Stadlmayr, Katharina Stadlbauer, Flávio Sádio, Peter Andorfer, Johannes Grillari, Florian Rüker, Gordana Wozniak-Knopp
Stabilization of the CD81 Large Extracellular Loop with De Novo Disulfide Bonds Improves Its Amenability for Peptide Grafting. Pharmaceutics 10 (3) (2018)